Yi-Bin Chen, MD
Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yi-Bin Chen, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:19 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04014790 · RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell TransplantationRegimmune Corporation · completed · Graft Vs Host Disease, Graft-versus-host-disease, Acute-graft-versus-host Disease · principal investigator
- Early Ph1NCT02733744 · Fecal Microbiota Transplantation After HSCTMassachusetts General Hospital · completed · Bone Marrow Transplantation · principal investigator
- Ph1/Ph2NCT02724904 · Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For LymphomaMassachusetts General Hospital · withdrawn · Lymphoma · principal investigator
- Ph1NCT02086513 · Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCTMassachusetts General Hospital · terminated · Graft Versus Host Disease · principal investigator
- Ph1NCT01940796 · Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)Massachusetts General Hospital · terminated · Graft-vs-Host Disease, GVHD · principal investigator
- Ph2NCT01643668 · Busulfan/Clofarabine + Allogeneic Stem Cell TransplantationMassachusetts General Hospital · completed · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph1NCT01596218 · Brentuximab Vedotin for Steroid Refractory GvHDMassachusetts General Hospital · completed · Graft vs. Host Disease · principal investigator
- Ph1NCT01398501 · Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell TransplantMassachusetts General Hospital · completed · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.